Zinc
Approved · EMAAlso known as Zinc, elemental, Zincum metallicum, Zn, Zn - Zinc.
Recent clinical, regulatory, research and industry developments relating to this drug.
The Effect of Probiotic and Zinc Supplementation in Patients With Gastroesophageal Reflux Disease
Cell-type-specific enhancement of deviance detection by synaptic zinc in the mouse auditory cortex.
Insight into brain metallothioneins from bidirectional Zn2+ signaling in synaptic dynamics.
Effects of a Supplementation With Zinc and Myo-inositol in Paediatric Obesity
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Regulatory timeline
The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.
Contains information from the European Medicines Agency (European Medicines Agency), © EMA, reused under CC BY 4.0.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- International journal of molecular sciences3
- Frontiers in endocrinology2
- Nutrients2
- Archives of ophthalmology (Chicago, Ill. : 1960)1
- Cell reports1
- Chemical reviews1
- Anderson CT3
- Bender PTR3
- Mendelson BZ3
- Manning A2
- McCollum M2
- Alterio V1
- Ayton S1
- Bainer K1
- Rockefeller Neuroscience Institute3
- "Apollonia" University of Iasi1
- "Grigore T. Popa" University of Medicine and Pharmacy1
- Center for Innovative Biomedicine and Biotechnology (CIBB)1
- Centre for Human Psychopharmacology1
- Centro Hospitalar e Universitário de Coimbra (CHUC)1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 9 of the same disease areas as Zinc in the shared literature.
Studied across 6 of the same disease areas as Zinc in the shared literature.
Studied across 3 of the same disease areas as Zinc in the shared literature.
Studied across 4 of the same disease areas as Zinc in the shared literature.
Studied across 3 of the same disease areas as Zinc in the shared literature.
Studied across 2 of the same disease areas as Zinc in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials
- Regulatory event sources are credited in the Regulatory Timeline above.